GTx, Inc. (NASDAQ:GTXI) has been assigned a consensus broker rating score of 1.00 (Strong Buy) from the two analysts that provide coverage for the company, Zacks Investment Research reports. Two analysts have rated the stock with a strong buy rating.
Analysts have set a one year consensus target price of $16.50 for the company and are predicting that the company will post ($0.39) earnings per share for the current quarter, according to Zacks. Zacks has also assigned GTX an industry rank of 184 out of 265 based on the ratings given to related companies.
A number of research firms have recently weighed in on GTXI. ValuEngine upgraded shares of GTX from a “sell” rating to a “hold” rating in a report on Wednesday, February 7th. BidaskClub downgraded shares of GTX from a “strong-buy” rating to a “buy” rating in a report on Wednesday, February 14th. Zacks Investment Research upgraded shares of GTX from a “sell” rating to a “hold” rating in a report on Wednesday, January 17th. Robert W. Baird began coverage on shares of GTX in a report on Tuesday, November 21st. They issued an “outperform” rating and a $17.00 target price on the stock. Finally, Stifel Nicolaus began coverage on shares of GTX in a research note on Thursday, November 9th. They set a “buy” rating for the company.
GTX (NASDAQ GTXI) traded up $1.16 during trading on Tuesday, hitting $16.71. 159,727 shares of the stock were exchanged, compared to its average volume of 91,030. GTX has a 12-month low of $2.73 and a 12-month high of $17.00. The company has a market cap of $334.98, a P/E ratio of -9.49 and a beta of 1.78.
In related news, insider Jason T. Shackelford sold 3,090 shares of GTX stock in a transaction dated Friday, January 5th. The shares were sold at an average price of $11.33, for a total transaction of $35,009.70. Following the completion of the transaction, the insider now directly owns 31,111 shares of the company’s stock, valued at approximately $352,487.63. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Henry Patton Doggrell sold 4,965 shares of GTX stock in a transaction dated Friday, January 5th. The stock was sold at an average price of $11.33, for a total transaction of $56,253.45. Following the transaction, the vice president now directly owns 54,804 shares of the company’s stock, valued at $620,929.32. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,364 shares of company stock valued at $174,074. 41.20% of the stock is owned by corporate insiders.
A number of institutional investors have recently added to or reduced their stakes in the business. Abingworth LLP purchased a new stake in GTX in the 3rd quarter valued at about $2,781,000. Caxton Corp purchased a new stake in GTX in the 3rd quarter valued at about $531,000. Millennium Management LLC purchased a new stake in GTX in the 4th quarter valued at about $749,000. EAM Investors LLC purchased a new stake in GTX in the 4th quarter valued at about $551,000. Finally, Bank of New York Mellon Corp purchased a new stake in GTX in the 2nd quarter valued at about $124,000. 11.96% of the stock is owned by institutional investors.
GTx, Inc is a biopharmaceutical company focused on the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for breast and prostate cancer, and other medical conditions. The Company is engaged in the development of selective androgen receptor modulators (SARMs).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for GTX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GTX and related companies with MarketBeat.com's FREE daily email newsletter.